National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
SCLC Tarlatamab Blood Collection
Not yet recruiting
25 enrolled
SCLC
Completed
272 enrolled
A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
Recruiting
500 enrolled
ARSENAL
Active not recruiting
254 enrolled
DP-04
Recruiting
100 enrolled
PHILUCA
Enrolling by invitation
160 enrolled
Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)
Completed
45 enrolled
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
Recruiting
50 enrolled
IMreal
Active not recruiting
2,756 enrolled
LUNGEVITY
Recruiting
1,000 enrolled
ES-SCLC
Recruiting
40 enrolled
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Recruiting
500 enrolled
PROPHETIC
Active not recruiting
10,000 enrolled
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Recruiting
700 enrolled
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Not yet recruiting
300 enrolled
Prospective Observational Study on ES-SCLC
Not yet recruiting
96 enrolled
SUCCEED
Recruiting
30 enrolled
A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)
Not yet recruiting
400 enrolled
Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer
Recruiting
38 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
NYULCBC
Recruiting
10,850 enrolled
ARAL
Completed
71 enrolled
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
Recruiting
40 enrolled
DOTATOC PET/CT for Imaging NET Patients
Active not recruiting
800 enrolled
PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases
Completed
46 enrolled
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
Recruiting
600 enrolled
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
Not yet recruiting
223 enrolled
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Recruiting
65 enrolled
Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer
Active not recruiting
600 enrolled
CRISP
Recruiting
12,400 enrolled
SCLC-OMICS
Recruiting
50 enrolled
EDUR-BRA
Active not recruiting
60 enrolled
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
Recruiting
Molecular Analysis and Treatment Options of SCLC
Recruiting
500 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
CLINATEZO
Completed
518 enrolled
PET-ART
Recruiting
30 enrolled
HYPE
Active not recruiting
20 enrolled
EPITAX
Completed
29 enrolled
A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer
Not yet recruiting
2,000 enrolled
Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer
Recruiting
70 enrolled
The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer
Active not recruiting
228 enrolled
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Recruiting
60,000 enrolled
REVEAL
Completed
45 enrolled
Real-World Study on the Efficacy of IBI-322 in Combination With Lenvatinib for the Treatment of Extensive Stage Small Cell Lung Cancer
Unknown
160 enrolled
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
Terminated
81 enrolled
ROSALIND
Recruiting
1,020 enrolled
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Completed
2,310 enrolled
Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study
Unknown
30 enrolled